About
Education & Training
Medical School
University Of Kentucky College Of Health Sciences
Internship
Internal Medicine
- University of Kentucky College of Medicine
Residency
Ophthalmology
- University of Kentucky College of Medicine
Fellowship
Vitreo - Retinal Disease
- Duke University Medical Center
Boards
Commercial Relationships and Collaborations
This faculty member or a member of his or her immediate family has a working relationship, such as providing consulting, research, or educational services, with the companies listed below. These relationships have been reported to the University of Missouri and, if appropriate, plans have been established to address potential conflicts. The following relationships were reported as of July 2020.
Katalyst Surgical, LLC
Insurances
MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.
Academic Information
Research Profile
As Director of the Clinical Research Center, I am involved in managing many clinical trials. As an Ophthalmology Professor, my research interests have been in diabetic retinopathy and macular degeneration. I am the Principle Investigator for the EDIC clinical trial, which is the longest running trial in the US examining the clinical course of patients with type I diabetes. I am currently examining a urine sensor for the presence of diabetic retinopathy, which may avoid yearly screening eye exams.
Research Interests
- Diabetic retinopathy
- Retinopathy of prematurity
- Ophthalmic screening biomarkers
Areas of Expertise
- Diabetic retinopathy
- Retinopathy of prematurity
- Ophthalmic screening biomarkers
Publications
- Nathan DM, Bebu I, Hainsworth DP, Klein R, Tamborlane W, Lorenzi G, Gubitosi-Klug R, Lachin JM; Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes. NEJM 2017;376(16):1507-16
- Lachin JM, White NH, Hainsworth DP, Sun W, Cleary PA, Nathan DM, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group; Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients with Type 1 Diabetes: 18 Years of Follow-Up in the DCCT/EDIC. Diabetes. 64(2):631-42, 2015 Feb.
- Soni C, Hainsworth DP, Almony A. Surgical management of rhegmatogenous retinal detachment: a meta-analysis of randomized controlled trials. Ophthalmology 2013; 120(7):1440-1447.
- Hubbard LD, Sun W, Cleary PA, Danis RP, Hainsworth DP, Peng Q, Susman RA, Aiello LP, Davis MD, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Group. Comparison of Digital and Film Grading of Diabetic Retinopathy Severity in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Arch Ophthalmol 2011;129:718-726.
- White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD, DCCT-EDIC Research Group. Effect of Prior Intensive Therapy in Type 1 Diabetes on 10-Year Progression of Retinopathy in the DCCT-EDIC: Comparison of Adults and Adolescents. Diabetes 2010;59:1244-1253.
- Hainsworth DP, Liu GT, Hamm CW, Katz ML. Funduscopic and Angiographic Appearance in the Neuronal Ceroid Lipofuscinoses. Retina 2009:29:659-668.
- White NH, Sun W, Cleary PA, Lachin J, Danis RR, Davis MD, Hubbard L, Hainsworth DP, for DCCT/EDIC. Prolonged Effect of Intensive Therapy on the Risk of Retinopathy Complications in Patients with Type 1 Diabetes: 10 years after the DCCT. Arch Ophthalmol 2008;126(12):1707-15.